Company intelligence / Profile preview

Vulintus

Lafayette, Colorado, United Statesvulintus.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vulintus has developed and commercialized several automated platforms that improve the throughput and objectivity of preclinical behavioral testing in rodents. Their MotoTrak system has been supported by NIH SBIR grants and adopted by academic labs and industry partners to enhance translational neuroscience research. The quality of data generated with their systems has contributed to advancing therapies from animal models into clinical trials.

Therapeutic areas: Neurology
Modalities: Device (preclinical behavioral assessment systems)Software (for data collection/analysis)
Industry: Drug Discovery Services

Partnerships

National Institutes of Health/NINDS via SBIR funding

Beyond the preview

Go deeper on Vulintus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vulintus.

Explore the full profile